Retatrutide 5mg – Research Peptide
For Laboratory Research Use Only. Not for Human Consumption.
Retatrutide is a next-generation investigational peptide designed as a triple agonist of GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This synthetic analog represents a powerful tool for cutting-edge metabolic research, offering multi-pathway modulation with broad implications for obesity, insulin resistance, and energy expenditure studies.
Key Research Attributes:
Triple Receptor Activation: Simultaneously targets GLP-1, GIP, and glucagon receptors, delivering potent metabolic synergy.
Appetite and Energy Regulation: Investigated for suppressing appetite while enhancing basal metabolic rate and lipid oxidation.
Advanced Metabolic Impact: Preclinical data suggest superior effects on weight reduction, insulin sensitivity, and fat mass loss compared to dual agonists.
Long-Acting Profile: Engineered for once-weekly administration in research models due to its extended half-life (~6 days).
Potential Research Applications:
Obesity modeling: Studies on extreme fat loss and adiposity reduction
Glucose homeostasis: Impact on insulin/glucagon balance and glycemic control
Energy expenditure: Investigation of thermogenesis and mitochondrial function
Combination therapy models: Synergy with other peptide hormones or metabolic agents
Product Specifications:
Content: 5mg lyophilized Retatrutide peptide
Purity: ≥98% (HPLC Verified)
Form: Sterile, white lyophilized powder
Storage: Store at -20°C; protect from light and moisture
Solubility: Reconstitutes in bacteriostatic water or appropriate research buffer
Disclaimer: This material is sold strictly for laboratory research use only. It is not intended for human consumption, clinical use, or therapeutic applications. All buyers must be qualified research professionals or entities. Handle in accordance with institutional safety protocols.
